Sitagliptin or exenatide once weekly for type 2 diabetes: comparison of the clinical trials

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.13, 2011-09, pp. : 2055-2067

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exenatide once weekly in type 2 diabetes mellitus

By Bischoff Lindsay A Jabbour Serge A Miller Jeffrey L

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1297-1303

Informa Healthcare

Access to resources Recommend Favorite

Comparison of once-weekly with twice-daily exenatide in the treatment of type 2 diabetes (DURATION-1 trial)

By Raskin Philip Mohan Alok

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2269-2271

Informa Healthcare

Access to resources Recommend Favorite

Weekly exenatide works wonders for type 2 diabetes

Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Comparative Efficacy of Vildagliptin and Sitagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A Matching-Adjusted Indirect Comparison of Randomized Trials

By Signorovitch James E.

Clinical Drug Investigation, Vol. 31, Iss. 9, 2011-09 ,pp. : 665-674

Adis International

Access to resources Recommend Favorite

Extending the evidence for exenatide in type 2 diabetes

Inpharma, Vol. 1, Iss. 1502, 2005-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite